<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35280874</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Long-Term Persistence of Olfactory and Gustatory Disorders in COVID-19 Patients.</ArticleTitle><Pagination><StartPage>794550</StartPage><MedlinePgn>794550</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">794550</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.794550</ELocationID><Abstract><AbstractText>Smell and taste disorders are frequent symptoms during acute COVID-19 and may persist long after the resolution of the initial phase. This study aims to estimate the proportion and risk factors for smell and/or taste disorders at the onset of symptoms and their persistence after more than 6 months of follow-up in COVID-19 patients. We analyzed a prospective cohort of COVID-19 patients admitted to our institute in Marseille, France in early 2020. After being discharged from the hospital, patients with smell and/or taste disorders were contacted for a telephone interview. Logistic regression analysis was performed to determine the risk factors for smell and/or taste disorders. A total of 3,737 patients were included, of whom 1,676 reported smell and/or taste disorders at the onset of symptoms. Taste and/or smell disorders were independently associated with being younger and female, a lower likelihood of suffering from diabetes, cardiovascular diseases and cancer, a longer delay between the onset of symptoms and consultation, and non-severe forms of COVID-19 at admission. Of the 605 patients with smell and/or taste disorders who were followed-up, 154 (25.5%) reported the persistence of symptoms for more than 6 months. At the time of follow-up, being female, having a chronic respiratory disease and using angiotensin-converting enzyme inhibitors (ACEis) were factors independently associated with the persistence of smell and/or taste disorders. In conclusion, the long-term persistence of olfactory and gustative disorders is frequent among COVID-19 patients, notably affecting female patients and patients who suffered from chronic respiratory diseases before infection. The role of ACEis needs to be further evaluated in larger numbers of patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Nguyen, Hoang, Dao, Meddeb, Cortaredona, Lagier, Million, Raoult and Gautret.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Nhu Ngoc</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IHU-M&#xe9;ditarran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoang</LastName><ForeName>Van Thuan</ForeName><Initials>VT</Initials><AffiliationInfo><Affiliation>Family Medicine Department, International Relations Department, Group for Research in Emerging and Re-Emerging Infectious Diseases, Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dao</LastName><ForeName>Thi Loi</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Family Medicine Department, International Relations Department, Group for Research in Emerging and Re-Emerging Infectious Diseases, Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pneumology Department, Group for Research in Emerging and Re-Emerging Infectious Diseases, Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meddeb</LastName><ForeName>Line</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IHU-M&#xe9;ditarran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortaredona</LastName><ForeName>S&#xe9;bastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IHU-M&#xe9;ditarran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagier</LastName><ForeName>Jean-Christophe</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>IHU-M&#xe9;ditarran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aix Marseille University, IRD, AP-HM, MEPHI, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Million</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IHU-M&#xe9;ditarran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aix Marseille University, IRD, AP-HM, MEPHI, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raoult</LastName><ForeName>Didier</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>IHU-M&#xe9;ditarran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aix Marseille University, IRD, AP-HM, MEPHI, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gautret</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IHU-M&#xe9;ditarran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistence</Keyword><Keyword MajorTopicYN="N">smell</Keyword><Keyword MajorTopicYN="N">taste</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>14</Day><Hour>5</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35280874</ArticleId><ArticleId IdType="pmc">PMC8915119</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.794550</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zaim S, Chong JH, Hons B, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr Probl Cardiol. (2020) 45:e100618. 10.1016/j.cpcardiol.2020.100618</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100618</ArticleId><ArticleId IdType="pmc">PMC7187881</ArticleId><ArticleId IdType="pubmed">32439197</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. (2020) 77:683&#x2013;90. 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y, Xu J, Chu M, Mai J, Lai N, Tang W, et al. . Neurosensory dysfunction: a diagnostic marker of early COVID-19. Int J Infect Dis. (2020) 98:347&#x2013;52. 10.1016/j.ijid.2020.06.086</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.086</ArticleId><ArticleId IdType="pmc">PMC7323654</ArticleId><ArticleId IdType="pubmed">32615326</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Freidin MB, Sudre CH, Nguyen LH, Drew DA, et al. . Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. (2020) 26:1037&#x2013;40. 10.1038/s41591-020-0916-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0916-2</ArticleId><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, Siati DRD, Horoi M, Bon SDL, Rodriguez A, et al. . Olfactory and gustatory dysfunction as a clinical presentation of milds-to-moderate forms of the coronavirus disease. Eur Arch Otorhinolaryngol. (2020) 277:2251&#x2013;61. 10.1007/s00405-020-05965-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier J-C, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A, et al. . Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine azithromycin and other regimens in Marseille, France- A retrospective analysis. Travel Med Infect Dis. (2020) 36:101791. 10.1016/j.tmaid.2020.101791</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101791</ArticleId><ArticleId IdType="pmc">PMC7315163</ArticleId><ArticleId IdType="pubmed">32593867</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xd8;raas A, B&#xd8; R, Kalleberg KT, St&#xd8;er NC, Ellingjord-Dale M, Inge N, et al. . Self-reported memory problems 8 months after COVID-19 infection. JAMA Netw Open. (2021) 4:e2118717. 10.1001/jamanetworkopen.2021.18717</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.18717</ArticleId><ArticleId IdType="pmc">PMC8322992</ArticleId><ArticleId IdType="pubmed">34323987</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NN, Hoang VT, Lagier J-C, Raoult D, Gautret P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin Microbiol Infect. (2021) 27:931&#x2013;2. 10.1016/j.cmi.2020.12.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.021</ArticleId><ArticleId IdType="pmc">PMC7784539</ArticleId><ArticleId IdType="pubmed">33418020</ArticleId></ArticleIdList></Reference><Reference><Citation>Amrane S, Tissot-Dupont H, Doudier B, Eldin C, Hocquart M, Mailhe M, et al. . Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: a respiratory virus snapshot. Travel Med Infect Dis. (2020) 36:101632. 10.1016/j.tmaid.2020.101632</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101632</ArticleId><ArticleId IdType="pmc">PMC7102626</ArticleId><ArticleId IdType="pubmed">32205269</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med. (2020) 46:357&#x2013;60. 10.1007/s00134-020-05954-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05954-2</ArticleId><ArticleId IdType="pmc">PMC7042184</ArticleId><ArticleId IdType="pubmed">32025779</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher AA, Laing JE, Stoeckel JE, Townsend J. Handbook for family planing operations research Design. (1991) 2:40&#x2013;3. 10.31899/rh10.1039</Citation><ArticleIdList><ArticleId IdType="doi">10.31899/rh10.1039</ArticleId></ArticleIdList></Reference><Reference><Citation>Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R. Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin Proc. (2020) 95:1621&#x2013;31. 10.1016/j.mayocp.2020.05.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.030</ArticleId><ArticleId IdType="pmc">PMC7275152</ArticleId><ArticleId IdType="pubmed">32753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorokowski P, Karwowski M, Misiak M, Marczak MK, Dziekan M, Hummel T, et al. . Sex differences in human olfaction: a meta-analysis. Front Psychol. (2019) 10:242. 10.3389/fpsyg.2019.00242</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2019.00242</ArticleId><ArticleId IdType="pmc">PMC6381007</ArticleId><ArticleId IdType="pubmed">30814965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorokowska A, Schriever VA, Gudziol V, Hummel C, H&#xe4;hner A, Iannilli E, et al. . Changes of olfactory abilities in relation to age: odor identification in more than 1400 people aged 4 to 80 years. Eur Arch Otorhinolaryngol. (2015) 272:1937&#x2013;44. 10.1007/s00405-014-3263-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-014-3263-4</ArticleId><ArticleId IdType="pmc">PMC4473282</ArticleId><ArticleId IdType="pubmed">25238811</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang N, Perez P, Kato T, Mikami Y, Okuda K, Gilmore RC, et al. . SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. (2021) 27:892&#x2013;903. 10.1038/s41591-021-01296-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01296-8</ArticleId><ArticleId IdType="pmc">PMC8240394</ArticleId><ArticleId IdType="pubmed">33767405</ArticleId></ArticleIdList></Reference><Reference><Citation>Woloshin S, Patel N, Kesselheim AS. False negative tests for SARS-CoV-2 infection - challenges and implications. N Engl J Med. (2020) 383:e38. 10.1056/NEJMp2015897</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2015897</ArticleId><ArticleId IdType="pubmed">32502334</ArticleId></ArticleIdList></Reference><Reference><Citation>Soci&#xe9;t&#xe9; Fran&#xe7;ais ORL,. Alerte Anosmie COVID-19 . (2020). Available onlne at: https://www.sforl.org/actualites-covid-19/ (accessed May 25, 2021).</Citation></Reference><Reference><Citation>O'Byrne L, Webster KE, MacKeith S, Philpott C, Hopkins C, Burton MJ. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev. (2021) 7:CD013877. 10.1002/14651858.CD013876.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013876.pub2</ArticleId><ArticleId IdType="pmc">PMC8406518</ArticleId><ArticleId IdType="pubmed">34291812</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi BY, Jeong H, Noh H, Park JY, Cho JH, Kim JK. Effects of olfactory training in patients with postinfectious olfactory dysfunction. Clin Exp Otorhinolaryngol. (2021) 14:88&#x2013;92. 10.21053/ceo.2020.00143</Citation><ArticleIdList><ArticleId IdType="doi">10.21053/ceo.2020.00143</ArticleId><ArticleId IdType="pmc">PMC7904423</ArticleId><ArticleId IdType="pubmed">32575977</ArticleId></ArticleIdList></Reference><Reference><Citation>Damm M, Pikart LK, Reimann H, Burkert S, G&#xf6;ktas &#xd6;, Haxel B, et al. . Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope. (2014) 124:826&#x2013;31. 10.1002/lary.24340</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.24340</ArticleId><ArticleId IdType="pubmed">23929687</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R, Han P, Reither N, Hummel T. Effectiveness of olfactory training on different severities of posttraumatic loss of smell. Laryngoscope. (2019) 129:1737&#x2013;43. 10.1002/lary.27832</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.27832</ArticleId><ArticleId IdType="pubmed">30848489</ArticleId></ArticleIdList></Reference><Reference><Citation>Altundag A, Cayonu M, Kayabasoglu G, Salihoglu M, Tekeli H, Saglam O, et al. . Modified olfactory training in patients with postinfectious olfactory loss. Laryngoscope. (2015) 125:1763&#x2013;6. 10.1002/lary.25245</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.25245</ArticleId><ArticleId IdType="pubmed">26031472</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon S-D, Konopnicki D, Pisarski N, Prunier L, Lechien JR, Horoi M. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell. Eur Arch Otorhinolaryngol. (2021) 278:3113&#x2013;7. 10.1007/s00405-020-06520-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06520-8</ArticleId><ArticleId IdType="pmc">PMC7796691</ArticleId><ArticleId IdType="pubmed">33423106</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel WW, Cross CL. Biostatistics: A foundation for Analysis in the Health Science. New York: John Wilet and Son. (1999). p. 189&#x2013;91.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>